Jeffrey H. Horowitz | People

Jeffrey Horowitz represents leading global pharmaceutical companies in a wide range of litigation and counseling matters. Jeffrey is an experienced trial lawyer who has represented a wide range of clients in major product liability and other complex litigation. Jeffrey's diverse practice also includes commercial litigation, government and internal investigations, regulatory and compliance counseling, and litigation risk and avoidance counseling.

Jeffrey has tried cases to verdict in federal and state courts around the country, including New York, California, Delaware, New Jersey, Maryland, and the District of Columbia. He is a member of the adjunct faculty as a Lecturer in Law at Columbia Law School, where he teaches trial practice. Prior to joining the firm, Jeffrey served as an Assistant Attorney General for the State of New York. During his tenure, Jeffrey represented New York in a wide variety of federal and state matters.

Focus Areas

Experience

International pharmaceutical company as global product liability counsel related to Covid-19 vaccine.
Pfizer national coordinating and trial counsel in Asbestos and Talc litigation.
Hospira, co-national counsel in litigation involving allegations of failure to adequately warn of hair loss related to the chemotherapy drug Docetaxel.
Viatris, national counsel in litigation involving allegations of cerebellar atrophy related to the antiepileptic Dilantin.
Bayer in national litigation involving allegations of bleeding events related to the anticoagulant Xarelto.

Pfizer trial counsel in national litigation involving allegations of birth defects related to the antidepressant Zoloft.
Pfizer, led trial strategy team in national litigation involving allegations of movement disorders related to the antiemetic drug Reglan.
AstraZeneca in national litigation and served as lead counsel in New York federal court cases involving allegations of chondrolysis associated with use of Pain Pumps.
AstraZeneca in national litigation involving allegations of diabetes related to the antipsychotic Seroquel.
Novartis in national litigation involving allegations of strokes related to PPA.
Pfizer in national litigation involving allegations of liver injuries related to the antidiabetic Rezulin.
Novartis in several one-off pharmaceutical product liability cases as lead counsel.
Multiple global pharmaceutical companies in pharmaceutical product liability cases involving allegations of Stevens-Johnson Syndrome.

Major brand name prescription drug manufacturer in qui tam litigation brought in Eastern District of Pennsylvania alleging off label and kickback claims under the False Claims Act.
International pharmaceutical company on legal and regulatory compliance issues related to sales and marketing practices, as well as pharmacovigilance and safety reporting requirements.
Major international pharmaceutical company in a federal investigation involving allegations of violations under the False Claims Act and Anti-Kickback Statute based on sales, marketing, and pricing practices.
Generic pharmaceutical company in a federal investigation stemming from a qui tam lawsuit alleging violations under the False Claims Act.
Conducted compliance review and analysis of a consumer healthcare company embedded in an international brand pharmaceutical manufacturer.

Sanofi-Aventis, as trial counsel, in patent infringement ANDA litigation against drug companies which sought to market generic versions of Allegra antihistamine products.
Pfizer, as trial counsel, in patent infringement ANDA litigation that resulted in successful defense of the patents covering the active ingredient in Celebrex.
Chiron, as trial counsel, in a case involving the patent covering its cystic fibrosis treatment, TOBI.
Obtained a substantial jury award, including punitive damages, for a French airplane parts manufacturer for willful patent and trade dress infringement, and unfair competition.
Successfully resolved a patent infringement action involving image sensor technology for use in camera modules placed in cell phones.

Perspectives

December 2022

Deskbook on Internal Investigations, Corporate Compliance, and White Collar Issues (2nd ed.)

Practising Law Institute

March 23, 2022

The PREP Act and COVID-19: Two Years Later

Advisory

June 2019

Deskbook on Internal Investigations, Corporate Compliance and White Collar Issues (2nd Edition)

PLI Practising Law Institute

Recognition

The Legal 500 U.S.

Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices—Defense (2021–2022)

Credentials

Education

J.D., Temple University School of Law, cum laude
B.A., with honors, Michigan State University

Admissions

New York
U.S. Court of Appeals for the Federal Circuit
U.S. District Court, Eastern District of New York
U.S. District Court, Southern District of New York

Activities

Chairman, Board of Directors, New York Center for Law and Justice